Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP-study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1991

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
GLP compliance:
yes
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Chemical structure
Reference substance name:
1-[2-chloro-4-(4-chlorophenoxy)phenyl]ethanone
EC Number:
601-639-3
Cas Number:
119851-28-4
Molecular formula:
C14H10Cl2O2
IUPAC Name:
1-[2-chloro-4-(4-chlorophenoxy)phenyl]ethanone

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Ibm: GOHI, SPF-quality
Sex:
female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
other: Intradermal induction: 5 % in Polyethylene glycol; Epidermal induction: 15 % in vaselinum album
Concentration / amount:
Pretest: 5; 3 and 1 % test article in polyethylene gylcol (intradermal injections (0.1 mL/site)
Main test induction: 5 % test article in polyethylene glycol
Main test challenge: 5 % in vaselinum album
Challengeopen allclose all
Route:
epicutaneous, semiocclusive
Vehicle:
other: Intradermal induction: 5 % in Polyethylene glycol; Epidermal induction: 15 % in vaselinum album
Concentration / amount:
Pretest: 5; 3 and 1 % test article in polyethylene gylcol (intradermal injections (0.1 mL/site)
Main test induction: 5 % test article in polyethylene glycol
Main test challenge: 5 % in vaselinum album
No. of animals per dose:
Number of animals main study/pretest: 30 females/6 females

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
other: Control group
Dose level:
0 % (right flank)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 24.0. Group: other: Control group. Dose level: 0 % (right flank). No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
1st reading
Hours after challenge:
48
Group:
other: Control group
Dose level:
0 % (right flank)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: other: Control group. Dose level: 0 % (right flank). No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
1st reading
Hours after challenge:
24
Group:
other: Control group
Dose level:
5 % (left flank)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 24.0. Group: other: Control group. Dose level: 5 % (left flank). No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
1st reading
Hours after challenge:
48
Group:
other: Control group
Dose level:
5 % (left flank)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: other: Control group. Dose level: 5 % (left flank). No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
5 % (left flank)
No. with + reactions:
5
Total no. in group:
20
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 5 % (left flank). No with. + reactions: 5.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
5 % (left flank)
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5 % (left flank). No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0 % (right flank)
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0 % (right flank). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
0 % (right flank)
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0 % (right flank). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
2nd reading
Hours after challenge:
24
Group:
other: Control group
Dose level:
0 % (left flank)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 2nd reading. . Hours after challenge: 24.0. Group: other: Control group. Dose level: 0 % (left flank). No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
2nd reading
Hours after challenge:
48
Group:
other: Control group
Dose level:
0 % (left flank)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: Control group. Dose level: 0 % (left flank). No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
2nd reading
Hours after challenge:
24
Group:
test chemical
Dose level:
5 % (right flank)
No. with + reactions:
8
Total no. in group:
20
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 2nd reading. . Hours after challenge: 24.0. Group: test group. Dose level: 5 % (right flank). No with. + reactions: 8.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
5 % (right flank)
No. with + reactions:
5
Total no. in group:
20
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5 % (right flank). No with. + reactions: 5.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
2nd reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0 % (left flank)
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 2nd reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0 % (left flank). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
0 % (left flank)
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured.
Remarks on result:
other: see Remark
Remarks:
Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0 % (left flank). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No toxic symptoms were evident in the guinea pigs of the control or test group. No death occured..

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information
Conclusions:
The results were interpreted according to the rating of Magnusson and Kligman (1969). The TS is considered to be a sensitizer.